U.S. Thrombectomy Devices Market Size, Trends, Growth & Outlook

U.S. Thrombectomy Devices Market by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025

Industry: Life Science | Report ID: FAMI-00245 | Published on: Sep, 2019 | View: 1541 | Share:         

Request Sample Enquire Before Buying Request Discount

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.

The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.

The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices. 

Key Benefits for U.S. Thrombectomy Devices Market:

The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.

The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.

The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.

Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.

U.S. Thrombectomy Devices Key Market Segments:

By Technology

Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices

By Type

Automated Thrombectomy Devices
Manual Thrombectomy Devices

By Disease

Peripheral Thrombectomy Devices
Coronary Thrombectomy Devices
Neural Thrombectomy Devices

By Utility

Reusable Thrombectomy Devices 
Disposable Thrombectomy Devices

Key Market Players

Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Penumbra, Inc.
Koninklijke Philips N.V.
AngioDynamics, Inc.
Terumo Corporation
Johnson and Johnson
Stryker Corporation
Capture Vascular, Inc.

The other players in the value chain include (profiles not included in the report)

Argon Medical Devices, Inc.
Inari Medical, Inc."
 

Get a sample pages of this report Click here

"CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations

3.5.2. Restraints

3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness

3.5.3. Opportunities

3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy

CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Mechanical thrombectomy devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast

4.3. Aspiration thrombectomy devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast

4.4. Rheolytic thrombectomy devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Automated thrombectomy devices

5.2.1. Market size and forecast

5.3. Manual thrombectomy devices

5.3.1. Market size and forecast

CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE

6.1. Overview

6.1.1. Market size and forecast

6.2. Neurovascular thrombectomy devices

6.2.1. Market size and forecast

6.3. Peripheral thrombectomy devices

6.3.1. Market size and forecast

6.4. Coronary thrombectomy devices

6.4.1. Market size and forecast

CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY

7.1. Overview

7.1.1. Market size and forecast

7.2. Reusable thrombectomy devices

7.2.1. Market size and forecast

7.3. Disposable thrombectomy devices

7.3.1. Market size and forecast

CHAPTER 8: COMPANY PROFILES

8.1. BOSTON SCIENTIFIC CORPORATION

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. JOHNSON & JOHNSON

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. MEDTRONIC PLC

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments

8.4. Stryker Corporation

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development

8.5. Teleflex Incorporated

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development

8.6. TERUMO MEDICAL CORPORATION

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development

8.7. KONINKLIJKE PHILIPS N.V.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments

8.8. Angiodynamics Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance

8.9. Penumbra, Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. Capture Vascular, Inc.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio"
 

Select License Type
  • Single User License $5370 USD
  • Multi-User License $6450 USD
  • Corporate User License $8995 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.